It targets bacterial cell walls, weakening them and ultimately leading to the destruction of the bacterial cells
Clinical trials for both Ozempic and Wegovy demonstrated consistent weight loss outcomes without site-dependent variations
Without randomized, long-term studies on the use of GLP-1 RAs in a large sample size of HS patients with a wide range of ages, comorbidities, risk factors, and sexes and without any confounding factors, it is difficult to conclusively determine whether GLP-1 RAs are a definitive treatment for HS
doi: 10.1038/IJO.2012.229 [DOI] [PMC free article] [PubMed] [Google Scholar] 63.Al-Massadi O, Fern J, Diguez C, Nogueiras R, Quiones M
Concentration and formulation considerations Higher concentration solutions generally absorb better because they maintain a stronger concentration gradient across the mucosal membrane